Cargando…

IgA Type Multiple Myeloma, Clinical Features, and Prognosis

Detalles Bibliográficos
Autores principales:	Wang, Ling, Jin, Feng-Yan, Li, Ying, Sun, Jing-Nan, Zhang, Jia-Jia, Tang, Ran, Zhong, Yu-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956780/ https://www.ncbi.nlm.nih.gov/pubmed/29722346 http://dx.doi.org/10.4103/0366-6999.231513

Ejemplares similares

A report on the syndrome of inappropriate anti-diuretic hormone secretion associated with multiple myeloma
por: Tang, Ran, et al.
Publicado: (2020)

IgA nephropathy in IgG kappa multiple myeloma
por: Couto, Maria Eduarda, et al.
Publicado: (2021)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
por: Lv, Yan, et al.
Publicado: (2023)

Serum IgA-Fibronectin Concentration and IgA Nephropathy Diagnosis in Adults With Glomerulonephritis: A Diagnostic Test Study
por: Suhail, Sufi M.
Publicado: (2021)

IgA nephropathy preceded by erythroderma with eosinophilia
por: Takatsu, Mina, et al.
Publicado: (2022)

IgA nephropathy with podocytic infolding glomerulopathy
por: Wang, Zhouyang, et al.
Publicado: (2023)

Detection of myeloma cell-derived microvesicles: a tool to monitor multiple myeloma load
por: Liu, Zhao-Yun, et al.
Publicado: (2023)

Neuromeningeal cryptoccocosis revealing IgA-λ multiple myeloma
por: Mtibaa, Latifa, et al.
Publicado: (2021)

Efficacy and safety of Telitacicept in patients with IgA nephropathy
por: Liang, Dongrui, et al.
Publicado: (2023)

Reactivation of IgA vasculitis after COVID-19 vaccination
por: Obeid, Michel, et al.
Publicado: (2021)

Crescentic Glomerulonephritis in IgA Multiple Myeloma: A Case Report
por: Moscoso-Solorzano, Grace T., et al.
Publicado: (2011)

Dexamethasone implant for immunogammopathy maculopathy associated with IgA multiple myeloma
por: Georgakopoulos, Constantine D., et al.
Publicado: (2019)

Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma
por: Gao, Tiantao, et al.
Publicado: (2022)

Bilateral Myelomatous Pleural Effusion in a Patient with IgA Kappa Multiple Myeloma
por: Asiamah, Rebecca, et al.
Publicado: (2017)

IgA Nephropathy in a Patient with IgG Myeloma
por: Lakshmi, B. Sangeeta, et al.
Publicado: (2018)

Clinical features and prognosis of multiple myeloma and orbital extramedullary disease: Seven cases report and review of literature
por: Hu, Wan-Li, et al.
Publicado: (2022)

Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant
por: Xue, Jun-biao, et al.
Publicado: (2022)

Diffuse alveolar hemorrhage caused by IgA deposition associated with multiple myeloma
por: Furube, Atsuki, et al.
Publicado: (2019)

Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma
por: Kawata, Yuki, et al.
Publicado: (2021)

Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?
por: Sefland, Øystein, et al.
Publicado: (2019)

A Case of Linear IgA Bullous Dermatosis Successfully Treated with Omalizumab
por: Patel, Nayankumar H, et al.
Publicado: (2020)

Development of IgA vasculitis after SARS‐CoV‐2 vaccination
por: Ogura, Yasuaki, et al.
Publicado: (2022)

Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy
por: Xia, Fang-Ying, et al.
Publicado: (2019)

Suppression of leukocyte chemotaxis by human IgA myeloma components
Publicado: (1976)

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories
por: Gkoliou, Glykeria, et al.
Publicado: (2023)

Clinical characteristics, treatments, and prognosis of patients with multiple primary carcinoma of head and neck
por: Liu, Kun, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
por: Mina, Roberto, et al.
Publicado: (2020)

Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy
por: Ji, Ling, et al.
Publicado: (2014)

Microbiota, IgA and Multiple Sclerosis
por: Boussamet, Léo, et al.
Publicado: (2022)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
por: Chakraborty, Rajshekhar, et al.
Publicado: (2021)

Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
por: Stafford, Lauren Stewart, et al.
Publicado: (2023)

IgA nephropathy associated with erythrodermic psoriasis: A case report
por: Zhang, Li, et al.
Publicado: (2019)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients
por: Bosseboeuf, Adrien, et al.
Publicado: (2020)

Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma
por: Ozga, Michael, et al.
Publicado: (2023)

In response to Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
por: Cosentino, Marco, et al.
Publicado: (2023)

Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients
por: Yan, Ge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8bri4f054qn33gmoutnj2nb0uk